Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

47.0K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
47.0K
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

132
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
132
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

234
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
234
Fundamental Mathematical Principles in Pharmacokinetics: Calculus and Graphs01:21

Fundamental Mathematical Principles in Pharmacokinetics: Calculus and Graphs

2.1K
The fundamental mathematical principles, such as calculus and graphs, play crucial roles in analyzing drug movement and determining pharmacokinetic parameters. Differential calculus examines rates of change and helps to determine the dissolution rate of drugs in biofluids, as well as how drug concentrations change over time. For instance, it can help calculate the rate of elimination of a drug from the body based on its concentration-time profile.
On the other hand, integral calculus focuses on...
2.1K
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

1.2K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.2K
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

133
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
133

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Glycemic variability and muscle loss in elderly type 2 diabetes: insights from continuous glucose monitoring and chest CT in 303 patients.

Frontiers in endocrinology·2026
Same author

Arabidopsis MYC2-ARF16-ABI5 complex functions as a transcriptional switch to regulate jasmonate, auxin, and abscisic acid signaling synergy.

Plant physiology·2026
Same author

Nitroxyl relieves acute kidney injury by suppressing SLC31A1-mediated cuproptosis in renal tubular epithelial cells.

Life sciences·2026
Same author

A prognostic exosome-related mRNAs risk signature correlates with the immune microenvironment in breast cancer.

Discover oncology·2026
Same author

<i>TIMP1</i> and <i>DPP4</i> Promote Tumor Progression by Regulating Lactate Metabolism in Papillary Thyroid Carcinoma.

Cancers·2026
Same author

Unveiling GDF-15: a new frontier in combating diabetic osteoporosis.

Frontiers in medicine·2026

相关实验视频

Updated: Sep 20, 2025

Humanized NOD/SCID/IL2r&#947;null (hu-NSG) Mouse Model for HIV Replication and Latency Studies
07:10

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

Published on: January 7, 2019

15.8K

多种药物组合治疗下的艾滋病毒动态:数学建模和数据拟合.

Ning Bai1,2,3, Rui Xu4,5

  • 1Complex Systems Research Center, Shanxi University, Taiyuan, 030006, Shanxi, China.

Journal of mathematical biology
|May 29, 2025
PubMed
概括

结合性艾滋病毒治疗,比如特诺福维尔二硫胺 (TDF),拉米武丁 (3TC) 和埃法维伦兹 (EFV) 等,比单一治疗更有效. 早期开始治疗和坚持治疗对于抑制病毒载量和成功管理艾滋病毒至关重要.

关键词:
数据拟合数据 拟合数据艾滋病毒感染 艾滋病毒感染多药组合疗法多药组合疗法药理动力学是什么 药理动力学药理动力学 药理动力学

更多相关视频

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

1.5K
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

18.0K

相关实验视频

Last Updated: Sep 20, 2025

Humanized NOD/SCID/IL2r&#947;null (hu-NSG) Mouse Model for HIV Replication and Latency Studies
07:10

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

Published on: January 7, 2019

15.8K
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

1.5K
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

18.0K

科学领域:

  • 传染病的数学建模 传染病的数学建模
  • 药理动力学和药理动力学
  • 计算生物学和生物信息学

背景情况:

  • 国家免费艾滋病抗病毒药物治疗手册 (2023) 建议TDF,3TC和EFV作为一线HIV治疗.
  • 了解组合治疗的必要性和不同疗法对病毒载荷动态的影响至关重要.

研究的目的:

  • 调查HIV病毒负载抑制多药组合治疗背后的原因.
  • 分析各种药物治疗方案对病毒载荷动态的影响.
  • 评估药物坚持对治疗结果的影响.

主要方法:

  • 开发了一个宿主内HIV感染模型,整合了病毒动态和药理动力学.
  • 采用两部分模型来描述药物度随着时间的推移.
  • 应用马尔科夫链蒙特卡罗 (MCMC) 与大都会-海斯廷斯 (M-H) 算法进行参数估计.

主要成果:

  • 单一治疗可以通过严格遵守来抑制病毒载量,但遵守的影响更为明显.
  • 与单一疗法相比,多药组合疗法显示了坚持效果的减少.
  • 早期启动一线治疗对于成功治疗艾滋病毒的结果至关重要.

结论:

  • 组合疗法对于有效抑制艾滋病毒病毒载量至关重要.
  • 药物坚持在单一疗法和组合疗法中起着不同的作用.
  • 及时启动抗逆转录病毒疗法可以提高治疗成功率,并指导临床实践.